Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: Relation to severity of Parkinsonism

Journal of Neurochemistry

Volumn 125, Issue 5, 2013, Pages 657-662

  Pifl, Christian ^a   Hornykiewicz, Oleh ^a   Blesa, Javier ^b,c   Adánez, Rebeca ^b,c   Cavada, Carmen ^d,e   Obeso, José A ^b,c  

^a Medical University of Vienna   (Austria)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

motor symptoms; MPTP; noradrenaline; Parkinson's disease; thalamus

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASYMPTOMATIC DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; MACACA FASCICULARIS; MOTOR CORTEX; MOUSE; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SYMPTOM; THALAMUS DORSOMEDIAL NUCLEUS; THALAMUS NUCLEUS; THALAMUS RETICULAR NUCLEUS; THALAMUS VENTRAL NUCLEUS; VENTROANTERIOR THALAMIC NUCLEUS; VENTROPOSTERIOR LATERAL THALAMIC NUCLEUS;

ANIMALS; DOPAMINE; MACACA FASCICULARIS; MALE; MPTP POISONING; NOREPINEPHRINE; PARKINSONIAN DISORDERS; SEROTONIN; SEVERITY OF ILLNESS INDEX; THALAMIC NUCLEI;

ANIMALIA; PARKINSONIA; PRIMATES;

EID: 84878019287     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12162     Document Type: Article

References (19)

1. Berridge C. W., and, Waterhouse B. D., (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 42, 33-84.
2. Blesa J., Pifl C., Sanchez-Gonzalez M. A., et al,. (2012) The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study. Neurobiol. Dis. 48, 79-91.
3. Bryan-Lluka L. J., Siebert G. A., and, Pond S. M., (1999) Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. Naunyn Schmiedebergs Arch. Pharmacol. 360, 109-115.
4. Buck K. J., and, Amara S. G., (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4- phenylpyridinium. Proc. Natl Acad. Sci. USA 91, 12584-12588.
5. Devoto P., Flore G., Pani L., and, Gessa G. L., (2001) Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol. Psychiatry 6, 657-664.
6. Freeman A., Ciliax B., Bakay R., Daley J., Miller R. D., Keating G., Levey A., and, Rye D., (2001) Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann. Neurol. 50, 321-329.
7. Galvan A., and, Wichmann T., (2008) Pathophysiology of parkinsonism. Clin. Neurophysiol. 119, 1459-1474.
8. García-Cabezas M. A., Rico B., Sánchez-González M. A., and, Cavada C., (2007) Distribution of the dopamine innervation in the macaque and human thalamus. Neuroimage 34, 965-984.
9. + within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience 40, 133-158.
10. Herrero M. T., Hirsch E. C., Kastner A., Ruberg M., Luquin M. R., Laguna J., Javoy-Agid F., Obeso J. A., and, Agid Y., (1993) Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 56, 499-511.
11. Lindvall O., Bjorklund A., Nobin A., and, Stenevi U., (1974) The adrenergic innervation of the rat thalamus as revealed by the glyoxylic acid fluorescence method. J. Comp. Neurol. 154, 317-347.
12. McCormick D. A., Pape H. C., and, Williamson A., (1991) Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog. Brain Res. 88, 293-305.
13. Melchitzky D. S., and, Lewis D. A., (2001) Dopamine transporter- immunoreactive axons in the mediodorsal thalamic nucleus of the macaque monkey. Neuroscience 103, 1033-1042.
14. Oke A. F., Carver L. A., Gouvion C. M., and, Adams R. N., (1997) Three-dimensional mapping of norepinephrine and serotonin in human thalamus. Brain Res. 763, 69-78.
15. Palkovits M., Zaborszky L., Brownstein M. J., Fekete M. I., Herman J. P., and, Kanyicska B., (1979) Distribution of norepinephrine and dopamine in cerebral cortical areas of the rat. Brain Res. Bull. 4, 593-601.
16. Pifl C., Schingnitz G., and, Hornykiewicz O., (1991) Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience 44, 591-605.
17. Pifl C., Hornykiewicz O., Giros B., and, Caron M. G., (1996) Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. J. Pharmacol. Exp. Ther. 277, 1437-1443.
18. Pifl C., Kish S. J., and, Hornykiewicz O,. (2012) Thalamic noradrenaline in Parkinson's disease: Deficits suggest role in motor and non-motor symptoms. Mov. Disord. 27, 1618-1624.
19. Szabo J., and, Cowan W. M., (1984) A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis). J. Comp Neurol. 222, 265-300.